Autism Screening

Martin’s Wellness is proud to partner with ClearStrand™ASD to introduce a groundbreaking new autism screening test. It’s a simple, non-invasive test designed for children aged 1 month to 48 months that makes the process of screening for autism faster, clearer, and more accessible. When autism is a concern, ClearStrand-ASD can help healthcare providers objectively rule it out early using a simple strand of hair. Take the next step today by connecting virtually with a ClearStrand telehealth partner to see if your child qualifies.

Autism, also called Autism Spectrum Disorder (ASD), is a neurobiological developmental condition that affects how a person communicates, behaves, and adapts to their surroundings. Affecting approximately 1 in 31 children, autism can impact learning, mental health, and quality of life. Yet, many families face long waits and confusing paths to diagnosis, as traditional methods often rely on behavioral observations and developmental checklists. While these are valuable detection tools, they can delay much-needed support.

Enter autism screening, the first step in identifying whether a child may benefit from a more comprehensive developmental evaluation. Screening is not a diagnosis, but rather a simple and non-invasive process designed to spot early indicators of developmental differences. Autism screening can help determine whether a child should undergo a more extensive evaluation, providing invaluable early detection.

Research indicates that children who receive early intervention services tend to experience better long-term outcomes in areas like social skills, communication, and learning. Given that many children aren’t diagnosed with autism until age four or later, autism screening can help bridge this gap by encouraging earlier support when it can truly make the biggest impact.

For this reason, Martin’s Wellness proudly offers a new, science-backed screening option through ClearStrand ASD. This cutting-edge, non-invasive autism screening test uses a small hair sample to detect a biomarker associated with autism, providing objective insight into autism risks in children as early as 1 month.

Autism is a spectrum. Therefore, it can look different from person to person. Anyone can have autism, regardless of sex, age, race, or ethnicity. However, CDC research indicates that boys get diagnosed with autism four times more often than girls.

There are common signs that may indicate the need for screening, especially in young children. Some of these indications include when children avoid eye contact, do not respond to their name, have delayed speech or limited use of gestures (e.g., waving or pointing), or display limited interest in playing with others. Other indications in children can include repetitive behaviors, like hand flapping or lining up toys, or when a child has intense reactions to sounds, textures, or changes in routine.

Family history also plays a role. For example, if a close relative has been diagnosed with ASD or other developmental or neurological conditions, the likelihood that a child could be on the spectrum can be increased. Also, children born pre-term or to fathers aged 45 years and older tend to have a higher likelihood of ASD. In all cases, early screening for autism can be a proactive step toward gaining a better understanding and providing more effective support.

ClearStand ASD’s test is a game-changer, enabling families to collaborate with their child's healthcare provider to plan the next steps earlier than ever before. It is the first and only objective laboratory screening test for autism proven to be valid for children between 1 and 48 months of age, using just a single strand of hair to detect a biomarker associated with autism.

Take the next step today by connecting virtually with a ClearStrand telehealth partner to see if your child qualifies for a prescribed screening kit.